3037 Drug rash induced by levothyroxine and ORAL desensitization

Tuesday, 9 December 2014
Exhibition Hall-Poster Area (Sul America)

Sérgio Duarte Dortas Junior, Msc , Clínica Médica, WAO Junior Member, Rio de Janeiro, Brazil

Franklin Moreira De Araujo , Universidade Iguaçu, Nova Iguaçu, Brazil

Cintia Ribas Souza, MD , Clínica Médica, Hospital Geral De Nova Iguaçu, Nova Iguaçu, Brazil

Eduardo Micmacher, PhD , Clínica Médica, Universidade Iguaçu, Nova Iguaçu, Brazil

Soloni Afra Pires Levy, MD , Alergia e Imunologia Clínica, Hospital São Zacharias, Rio de Janeiro, Brazil

Augusto Tiaqui Abe, MD , Alergia e Imunologia Clínica, Hospital São Zacharias, Rio de Janeiro, Brazil

Alfeu Tavares França, PhD , Clínica Médica - Imunologia Clínica, Hospital Universitário Clementino Fraga Filho Hucff-Ufrj, Rio de Janeiro, Brazil

Background: Synthetic Thyroxine (T4) is the treatment of choice for the correction of hypothyroidism.

Methods: We report a case of drug rash induced by levothyroxine and currently oral desensitization.

A 31 year-old woman had been diagnosed as Hashimoto´s Thyroiditis. She was having levothyroxine for 9 years when she begun to present bilateral eyelids maculopapular rash. Blood exams and physical examination were normal except for the eyelids´ rash.

As she stopped using levothyroxine, the rash has disappeared.

Her endocrinologist prescribed her other brands of levothyroxine, and the patient reported the same reaction.

Results: Therefore, we performed an oral desensitization with multiple doses of the drug preparation. The procedure was started at a dose of 1,00µg. Every 30 minutes the dose was increased until a total dose of 127,00µg.

After 2 months, she currently tolerates 100,00µg/d.

Conclusions: It is unusual that biological substances induce allergic reactions when given exogenously.

Once it happens, drug desensitization can be performed at a hospital by experienced professionals with satisfactory response.